Alex G. Howarth

Alex G. Howarth joined Lycera as Chief Financial Officer in 2015, bringing more than 25 years of experience in healthcare and financial advisory roles. Most recently, Mr. Howarth served as Executive Vice President and Chief Financial Officer of moksha8. During his tenure as a key member of the executive team, he played a leading role in defining an organizational strategy to build the company and establish its global business. Prior to this, Mr. Howarth was Chief Business Officer at Vitae Pharmaceuticals, where he led the company’s alliances with GlaxoSmithKline (GSK) and Boehringer Ingelheim GmbH.

Previously, Mr. Howarth held senior positions at GSK, including as Senior Director, Worldwide Business Development, executing licensing transactions across all phases of development in diverse therapeutic areas, and then as Head, Venture Partnerships focused on partnering GSK’s clinical assets globally. Before this, he worked at KPMG, where he qualified as a chartered accountant.

Mr. Howarth received his BSc degree in biochemistry from the University of Bath, UK, and conducted molecular biology and neuroscience research at Celltech and Merck.